Prostate cancer test is too risky, say doctors
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Doctors have warned against introducing a national screening programme for prostate cancer, because of concerns that the risks posed by the test are greater than its potential benefits.
Experts on the UK National Screening Committee recommended that the PSA blood test should not be introduced on a systematic basis as it is untrustworthy.
It has been claimed that the test leads to over-diagnosis as it cannot distinguish between cancer and other conditions, such as a benign enlargement of the prostate or a urinary infection. Nor is a negative result fully reliable, as it can miss a tumour and dangerously provide a false reassurance.
Dr Anne Mackie, the screening committee director, said: "I am confident that this is the right decision. This advice is based on the latest research evidence, and informed by a range of groups, including healthcare professionals and patient representatives. The NHS Cancer Screening Programme will continue to provide advice to help men who are concerned about prostate cancer to make informed decisions about their health."
However, John Neate, chief executive of the Prostate Cancer Charity, called the announcement "extremely disappointing". He argued that "for some men with aggressive prostate cancer, but no symptoms, the PSA test will be the only early indicator of the cancer at a time when effective treatment can be offered".
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments